Oseltamivir for influenza in pregnancy

Seminars in Perinatology

Volumn 38, Issue 8, 2014, Pages 503-507

  Beigi, Richard H ^a   Venkataramanan, Raman ^b,c   Caritis, Steve N ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Influenza; Oseltamivir; Pharmacology; Pregnancy

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; DRUG METABOLITE; INFLUENZA VACCINE; ORGANIC ANION TRANSPORTER 1; OSELTAMIVIR; ANTIVIRUS AGENT;

2009 H1N1 INFLUENZA; AREA UNDER THE CURVE; ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG STRUCTURE; DRUG TRANSPORT; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MAXIMUM PLASMA CONCENTRATION; PANDEMIC INFLUENZA; PLACENTAL TRANSFER; PLASMA CONCENTRATION-TIME CURVE; PREGNANCY; PRENATAL DRUG EXPOSURE; RECOMMENDED DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT OUTCOME; FEMALE; INFLUENZA, HUMAN; PREGNANCY COMPLICATIONS, INFECTIOUS;

ANTIVIRAL AGENTS; FEMALE; HUMANS; INFLUENZA, HUMAN; OSELTAMIVIR; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84918583325     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2014.08.015     Document Type: Review

References (38)

1. CDC Prevention and control of influenza with vaccines. Recommendations of the advisory committee on immunization practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep 2010, 59(RR-8):1-62.
2. Irving W.L., James D.K., Stephenson T., et al. Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study. BJOG 2000, 107:1282-1289.
3. Neuzil K.M., Reed G.W., Mitchel E.F., Simonsen L., Griffin M.R. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol 1998, 148:1094-1102.
4. Beigi R.H. Clin Obstet Gynecol 2012, 55(4):914-926.
5. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374(9688):451-458.
6. Siston A.M., Rasmussen S.A., Honein M.A., et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. J Am Med Assoc 2010, 303(15):1517-1525.
7. Louie J.K., Acosta M., Jamieson D.J., Honein M.A., California Pandemic (H1N1) Working Group Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010, 362(1):27-35.
8. Sheffield J.S., Cunningham F.G. Community-acquired pneumonia in pregnancy. Obstet Gynecol 2009, 114(4):915-922.
9. Naresh A., Fisher B.M., Hoppe K.K., et al. A multicenter cohort study of pregnancy outcomes among women with laboratory-confirmed H1N1 influenza. J Perinatol 2013, 33(12):939-943.
10. Hewagama S., Walker S.P., Stuart R.L., et al. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin Infect Dis 2010, 50(5):686-690.
11. Mendez-Figueroa H., Raker C., Anderson B.L. Neonatal characteristics and outcomes of pregnancies complicated by influenza infection during the 2009 pandemic. Am J Obstet Gynecol 2011, 204(6 suppl 1):S58-S63.
12. ACOG Committee Opinion No 468: influenza vaccination during pregnancy. Obstet Gynecol 2010, 116:1006-1007. ACOG Committee on Obstetric Practice.
13. Centers for Disease Control and Prevention (CDC). Pregnant women and flu vaccination, Internet Panel Survey, United States, November 2013. 〈〉 Accessed 20.01.14. http://www.cdc.gov/flu/fluvaxview/pregnant-women-nov2013.htm.
14. Healthy People 2020. Topics and objectives: immunizations and infectious diseases, IID-12.10. 〈〉 Accessed 20.01.14. http://www.healthypeople.gov/2020/topics-objectives2020/objectiveslist.aspx?topicId=23.
15. CDC. 2011-2012 influenza antiviral medications: summary for clinicians. 〈〉 Accessed 20.01.14. http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm.
16. Jefferson T., Demicheli V., Deeks J., Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 2000, (2):CD001265.
17. Tanaka T., Nakajima K., Murashima A., Garcia-Bournissen F., Koren G. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breasfeeding women. CMAJ 2009, 181(1-2):55-58.
18. Greer L.G., Sheffield J.S., Rogers V.L., Roberts S.W., Mcintire D.D., Wendell G.D. Maternal and neonatal outcomes after antepartum treatment of influenza with antiviral medications. Obstet Gynecol 2010, 115:711-716.
19. Beigi R.H., Han K., Venkataramanan R., et al. Pharmacokinetics of oseltamivir among pregnant and nonpregnant women. Am J Obstet Gynecol 2011, 204(6 suppl 1):S84-S88.
20. Donner B., Viswanathan N., Hoffman G. Safety of oseltamivir in pregnancy: a review of preclinical and clinical data. Drug Saf 2010, 33(8):631-642.
21. Xie H.Y., Yasseen A.S., Xie R.H., et al. Infant outcomes among pregnant women who used oseltamivir for treatment of influenza during the H1N1 epidemic. Am J Obstet Gynecol 2013, 208(293):e1-e7.
22. Saito S., Minakami H., Nakai A., Unno N., Kubo T., Yoshimura Y. Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009. Am J Obstet Gynecol 2013, 209(130):e1-e9.
23. Matheson N.J., Symmonds-Abrahams M., Sheikh A., Shepperd S., Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev 2003, (3):CD002744.
24. Hsu J., Santesso N., Mustafa R., et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med 2012, 156(7):512-524.
25. Creanga A.A., Johnson T.F., Graitcer S.B., et al. Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women. Obstet Gynecol 2010, 115(4):717-726.
26. Anderson G.D. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005, 44(10):989-1008.
27. Hebert M.F., Ma X., Naraharisetti S.B., et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009, 85(6):607-614.
28. Buchanan M.L., Easterling T.R., Carr D.B., et al. Clonidine pharmacokinetics in pregnancy. Drug Metab Dispos 2009, 37(4):702-705.
29. Andrew M.A., Easterling T.R., Carr D.B., et al. Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther 2007, 81(4):547-556.
30. Eval S., Easterling T.R., Carr D.B., et al. Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos 2010, 38:833-840.
31. Dutkowski R., Thakrar B., Froehlich E., Suter P., Oo C., Ward P. Safety and pharmacology of oseltamivir in clinical use. Drug Safety 2003, 26(11):787-801.
32. McSharry J.J., Weng Q., Brown A., Kulaway R., Drusano G.L. Prediction of the pharmacodynamically linked variable of oseltamivir carboxylate for influenza A virus using an in vitro hollow-fiber infection model system. Antimicrob Agents Chemother 2009, 53:2375-2381.
33. Mirochnick M., Clarke D. Oseltamivir pharmacokinetics in pregnancy: a commentary. Am J Obstet Gynecol 2011, 204:S94-S95.
34. Greer L.G., Leff R.D., Laibl Rogers V., et al. Pharmacokinetics of oseltamivir according to trimester of pregnancy. Am J Obstet Gynecol 2011, 204:S89-S93.
35. Worley K.C., Roberts S.W., Bawdon R.E. The metabolism and transplacental transfer of oseltamivir in the ex vivo human model. Infect Dis Obstet Gynecol 2008, 2008:927574.
36. Berveiller P., Mir O., Vinot C., et al. Transplacental transfer of oseltamivir and its metabolite using the human perfused placental cotyledon model. Am J Obstet Gynecol 2012, 206(92):e1-e6.
37. Nanovskaya T.N., Patrikeeva S., Zhan Y., Hankins G.D.V., Ahmed M.S. Transplacental transfer of oseltamivir carboxylate. J Matern Fetal Neonatal Med 2012, 25(11):2312-2315.
38. Meijer W.J., Bruinse H.W., van den Broek M.P., Kromdijk W., Wensing A.M. Oseltamivir and its active metabolite cross the placenta at significant levels. Clin Infect Dis 2012, 54:1676-1677.